COVID-19 and cancer research by Harris, AL

Development of cancer metabolism as a therapeutic target: New pathways, patient studies, stratification and combination therapy by Harris, AL

The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-sma... by Giatromanolaki, A, Harris, AL, Koukourakis, MI

Landscape of transcriptomic interactions between breast cancer and its microenvironment by Fox, NS, Haider, S, Boutros, PC, Harris, AL

Pharmacodynamic and pharmacokinetic markers for anti-angiogenic cancer therapy: Implications for dosing and selection of patients. by Morotti, M, Dass, P, Harris, AL, Lord, SR

Downregulation of type I IFN response in hypoxia as a possible mechanism of immune escape by Miar, A, Rehwinkel, J, Zois, C, Harris, AL

Endogenous miRNA sponges mediate the generation of oscillatory dynamics for a non-coding RNA network by Dhawan, A, Harris, AL, Buffa, FM, Scott, JG

Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration by Giatromanolaki, A, Harris, AL, Banham, AH, Contrafouris, CA, Koukourakis, MI

Dissecting the heritable risk of breast cancer: from statistical methods to susceptibility genes by Fanfani, V, Zatopkova, M, Harris, AL, Pezzella, F, Stracquadanio, G

Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy by Koukourakis, MI, Giatromanolaki, A, Winter, S, Sivridis, E, Leek, R, Harris, AL

Metabolic reprogramming in colon cancer cells persistently infected with Newcastle disease virus by Yu, T, Jadhav, AC, Xu, J, Harris, AL, Nair, V, Huang, WE

Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis by Giatromanolaki, A, Koukourakis, IM, Balaska, K, Mitrakas, AG, Harris, AL, Koukourakis, MI

Investigations on zinc isotope fractionation in breast cancer tissue using in vitro cell culture uptake-efflux experiments by Schilling, K, Harris, AL, Halliday, AN, Schofield, CJ, Sheldon, H, Haider, S, Larner, F

Unveiling cancer metabolism through spontaneous and coherent Raman spectroscopy and stable isotope probing by Xu, J, Yu, T, Zois, CE, Cheng, JX, Tang, Y, Harris, AL, Huang, WE

Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer by Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL

Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs by Arnaiz, E, Miar, A, Bridges, E, Prasad, N, Hatch, SB, Ebner, D, Lawrie, CH, Harris, AL

Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2 by Choudhry, H, Schödel, J, Oikonomopoulos, S, Camps, C, Grampp, S, Harris, AL, Ratcliffe, PJ, Ragoussis, J, Mole, DR

A cellular basis for mapping behavioural structure by El-Gaby, M, Harris, AL, Whittington, JCR, Dorrell, W, Bhomick, A, Walton, ME, Akam, T, Behrens, TEJ

ADGRL4/ELTD1 silencing in endothelial cells induces ACLY and SLC25A1 and alters the cellular metabolic profile by Favara, DM, Zois, CE, Haider, S, Pires, E, Sheldon, H, McCullagh, J, Banham, AH, Harris, AL

Hypoxia induces transcriptional and translational downregulation of the type I IFN pathway in multiple cancer cell types by Miar, A, Arnaiz, E, Bridges, E, Beedie, S, Cribbs, AP, Downes, DJ, Beagrie, RA, Rehwinkel, J, Harris, AL